Power Law company profile

Acacia Pharma

Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2006 · IPO 2018 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$217M

Market cap · 2026

Revenue

$61M

Latest reported FY

Investors

6 investors on Acacia Pharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Series B+ 3 investors entered at this stage

Global footprint

Web traffic by country

980 monthly visits
across markets

🇺🇸 United States81.6%

🇨🇱 Chile10.2%

🇮🇳 India0%

Top 3 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo